OnKure Therapeutics (OKUR) Capital Expenditures (2020 - 2026)
OnKure Therapeutics (OKUR) posted Capital Expenditures of $3,000 for Q2 2026, down 76.9% from $13,000 a year earlier and down 40.0% from the prior quarter.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Capital Expenditures (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at OnKure Therapeutics was $23,000, down 64.1% year-over-year; for FY2025, it was $46,000, down 11.5% from FY2024.
- Annual Capital Expenditures has declined for three consecutive years, though with a five-year compound annual growth rate of 13.9% (FY2020 to FY2025).
- In prior years, OnKure Therapeutics' Capital Expenditures was $52,000 in FY2024 (-78.9%), $246,000 in FY2023 (-28.9%), $346,000 in FY2022 (+74.7%) and $198,000 in FY2021 (+725.0%).
- The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q1 2020.
- On a year-over-year basis, Capital Expenditures has declined in each of the last four quarters, with an average decline of 25.1% over the last eight quarters.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q4 2021, with growth of 462.5%; the weakest was Q1 2024, with a decline of 94.8%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $5,000 (Q1 2026), $9,000 (Q4 2025) and $6,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 533.00 Mn |
| 10 | OnKure Therapeutics | 125.92 Mn | -372.00 Mn | - | 3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 172,000.00 |
| Dec 31, 2022 | 250,000.00 |
| Sep 30, 2022 | 28,000.00 |
| Jun 30, 2022 | 24,000.00 |
| Mar 31, 2022 | 44,000.00 |
| Dec 31, 2021 | 90,000.00 |
| Sep 30, 2021 | 77,000.00 |
API Access
OnKure Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();